T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

Fiche publication

Date publication

juin 2019

Journal

Seminars in arthritis and rheumatism

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GANGI Afshin , Pr GOTTENBERG Jacques-Eric , Pr MARTIN Thierry

Tous les auteurs :
Poindron V, Chatelus E, Canuet M, Gottenberg JE, Arnaud L, Gangi A, Gavand PE, Guffroy A, Korganow AS, Germain P, Sibilia J, Ghannudi SE, Martin T

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31301817

Résumé

cardiac involvement is the second most frequent systemic sclerosis (SSc) related cause of death. It remains mostly asymptomatic in the early stage and is underdiagnosed with routine screening. Cardiac magnetic resonance imaging (CMR) could improve cardiac assessment of patients and noteworthily, new sequences allow the detection of diffuse myocardial fibrosis (DMF) by native T1 mapping. The aim of this study was to determine the prevalence of cardiac involvement by CMR native T1 mapping and its correlation with echocardiography data and non-cardiac manifestations in SSc patients.